Elevated Levels of IL-10 and G-CSF Associated with Asymptomatic Malaria in Pregnant Women

In sub-Saharan Africa, approximately 30 million pregnant women are at risk of contracting malaria annually. Nearly 36% of healthy pregnant women receiving routine antenatal care tested positive for Plasmodium falciparum HRP-II antigen in Ghana. We tested the hypothesis that asymptomatic HRP II positive pregnant women expressed a unique Th1 and Th2 phenotype that differs from healthy controls. Plasma from healthy (n = 15) and asymptomatic (n = 25) pregnant women were evaluated for 27 biomarkers (IL-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL- 17, Eotaxin, bFGF-2, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-bb, RANTES, TNF, and VEGF) associated with Th1 and Th2 cytokine homeostasis. IL-10 and G-CSF levels were elevated in the asymptomatic group when compared with the healthy group (P = .031 and .041, resp.). The median ratios of IL-1β:5, IL-1β:10, IL-1β:G-CSF, IL-1β:Eotaxin, IL-12:G-CSF, IL-15:10, IL-17:G-CSF, IL-17:Eotaxin, TNF:IL-4, TNF:IL-5, and TNF:G-CSF were significantly different among the two groups. Thus, asymptomatic malaria carriage may be linked to circulating levels of IL-10 and G-CSF.

[1]  J. Rayner,et al.  Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence and risk factors. , 2009, The American journal of tropical medicine and hygiene.

[2]  R. Snow,et al.  Evidence for Over-Dispersion in the Distribution of Clinical Malaria Episodes in Children , 2008, PloS one.

[3]  R. Ned,et al.  Malaria Journal Plasma Ip-10, Apoptotic and Angiogenic Factors Associated with Fatal Cerebral Malaria in India , 2008 .

[4]  J. Kurtis,et al.  Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria , 2008, Malaria Journal.

[5]  Venkatachalam Udhayakumar,et al.  Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children , 2007, Malaria Journal.

[6]  V. do Rosário,et al.  Epidemiological characterization of Plasmodium falciparum in the Republic of Cabo Verde: implications for potential large-scale re-emergence of malaria , 2006, Malaria Journal.

[7]  David L Smith,et al.  Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant Malaria , 2006, PLoS medicine.

[8]  M. T. Marrelli,et al.  Asymptomatic Carriers of Plasmodium spp. as Infection Source for Malaria Vector Mosquitoes in the Brazilian Amazon , 2005, Journal of medical entomology.

[9]  V. Titanji,et al.  Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. , 2005, The American journal of tropical medicine and hygiene.

[10]  M Tanner,et al.  A prospective study of Plasmodium falciparum multiplicity of infection and morbidity in Tanzanian children. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  O. Doumbo,et al.  Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe Plasmodium falciparum Malaria and Matched Uncomplicated Malaria or Healthy Controls , 2004, Infection and Immunity.

[12]  G. Dorsey,et al.  Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children , 2004, Tropical medicine & international health : TM & IH.

[13]  C. Drakeley,et al.  Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya , 2004, Malaria Journal.

[14]  B. Knols,et al.  Infectivity of Plasmodium falciparum gametocytes in patients attending rural health centres in western Kenya. , 2004, East African medical journal.

[15]  Z. Premji,et al.  Higher IL‐10 levels are associated with less effective clearance of Plasmodium falciparum parasites , 2004, Parasite immunology.

[16]  Ainong Zhou,et al.  Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. , 2003, The American journal of tropical medicine and hygiene.

[17]  G. Fouda,et al.  Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. , 2003, The Journal of infectious diseases.

[18]  B. Lell,et al.  Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Alifrangis,et al.  Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker , 2003, Malaria Journal.

[20]  B. Lell,et al.  New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. , 2002, The American journal of tropical medicine and hygiene.

[21]  C. Wongsrichanalai,et al.  Histidine-Rich Protein II: a Novel Approach to Malaria Drug Sensitivity Testing , 2002, Antimicrobial Agents and Chemotherapy.

[22]  D McGuinness,et al.  Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. , 2001, The Journal of infectious diseases.

[23]  B. Lell,et al.  Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. , 2000, The Journal of infectious diseases.

[24]  H. Ishida,et al.  Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection. , 2000, The Journal of veterinary medical science.

[25]  S. Khusmith,et al.  Complicated malaria is associated with differential elevations in serum levels of interleukins 10, 12, and 15. , 1999, The Southeast Asian journal of tropical medicine and public health.

[26]  Svensson,et al.  Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. , 1999, The Journal of infectious diseases.

[27]  A. Taylor-Robinson,et al.  A dichotomous role for nitric oxide in protection against blood stage malaria infection. , 1999, Immunology letters.

[28]  Christl A. Donnelly,et al.  Immunity to non-cerebral severe malaria is acquired after one or two infections , 1999, Nature Medicine.

[29]  J. Stopple,et al.  First‐Trimester Human Chorionic Villi Express Both Immunoregulatory and Inflammatory Cytokines: A Role for Interleukin‐10 in Regulating the Cytokine Network of Pregnancy , 1999, American journal of reproductive immunology.

[30]  V. Adabayeri,et al.  Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria , 1998, The Lancet.

[31]  L. Hviid,et al.  The Role of Variant-specific Immunity in Asymptomatic Malaria Infections: Maintaining a Fine Balance. , 1998, Parasitology today.

[32]  G. Grau,et al.  Profiles of cytokine production in relation with susceptibility to cerebral malaria. , 1993, Journal of immunology.

[33]  Jaeger,et al.  Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites , 1992, Infection and immunity.

[34]  M. van den Broek,et al.  Cytokines inhibit the development of liver schizonts of the malaria parasite plasmodium berghei in vivo , 1992, European journal of immunology.

[35]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[36]  S. Reed,et al.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.

[37]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[38]  A. Sher,et al.  Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. , 1991, Journal of immunology.

[39]  R. Locksley,et al.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  V. Nussenzweig,et al.  γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.

[41]  B. Greenwood,et al.  Asymptomatic malaria infections--do they matter? , 1987, Parasitology today.

[42]  C. Dye,et al.  World Malaria Report, 2008. , 2008 .

[43]  S. White,et al.  RNAi-mediated chromatin silencing in fission yeast. , 2008, Current topics in microbiology and immunology.

[44]  F. Granath,et al.  Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population. , 2007, Microbes and infection.

[45]  P. Kremsner,et al.  Uncomplicated malaria. , 2005, Current topics in microbiology and immunology.

[46]  Weltgesundheitsorganisation World malaria report , 2005 .

[47]  C. Wongsrichanalai,et al.  Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. , 2003, Wiener klinische Wochenschrift.

[48]  P. Bloland,et al.  Combination therapy for malaria in Africa: hype or hope? , 2000, Bulletin of the World Health Organization.

[49]  G. Snounou,et al.  Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[50]  B. Nahlen,et al.  A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. , 1999, The Journal of infectious diseases.

[51]  C. Rogier,et al.  Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[52]  北林 淳 Granulocyte Colony-Stimulating Factor Downregulates Allogeneic Immune Responses by Posttranscriptional Inhibition of Tumor Necrosis Factor-α Production , 1996 .

[53]  W. Graninger,et al.  Elevated Serum Levels of IL-10 and IFN-γ in Patients with Acute Plasmodium falciparum Malaria , 1995 .

[54]  M. Hirokawa,et al.  Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production. , 1995, Blood.